HPV-16 L1 genes with inactivated negative RNA elements induce potent immune responses - PubMed (original) (raw)
. 2004 Apr 25;322(1):182-9.
doi: 10.1016/j.virol.2004.02.002.
Lisen Arnheim, Brian Collier, Daniel Oberg, Håkan Hall, Jonas Klingström, Joakim Dillner, Diana V Pastrana, Chris B Buck, Jorma Hinkula, Britta Wahren, Stefan Schwartz
Affiliations
- PMID: 15063127
- DOI: 10.1016/j.virol.2004.02.002
Free article
HPV-16 L1 genes with inactivated negative RNA elements induce potent immune responses
Erik Rollman et al. Virology. 2004.
Free article
Abstract
Introduction of point mutations in the 5' end of the human papillomavirus type 16 (HPV-16) L1 gene specifically inactivates negative regulatory RNA processing elements. DNA vaccination of C57Bl/6 mice with the mutated L1 gene resulted in improved immunogenicity for both neutralizing antibodies as well as for broad cellular immune responses. Previous reports on the activation of L1 by codon optimization may be explained by inactivation of the regulatory RNA elements. The modified HPV-16 L1 DNA that induced anti-HPV-16 immunity may be seen as a complementary approach to protein subunit immunization against papillomavirus.
Similar articles
- Plasmid encoding papillomavirus Type 16 (HPV16) DNA constructed with codon optimization improved the immunogenicity against HPV infection.
Cheung YK, Cheng SC, Sin FW, Xie Y. Cheung YK, et al. Vaccine. 2004 Dec 16;23(5):629-38. doi: 10.1016/j.vaccine.2004.07.010. Vaccine. 2004. PMID: 15542183 - Nasal immunization of mice with human papillomavirus type 16 (HPV-16) virus-like particles or with the HPV-16 L1 gene elicits specific cytotoxic T lymphocytes in vaginal draining lymph nodes.
Dupuy C, Buzoni-Gatel D, Touzé A, Bout D, Coursaget P. Dupuy C, et al. J Virol. 1999 Nov;73(11):9063-71. doi: 10.1128/JVI.73.11.9063-9071.1999. J Virol. 1999. PMID: 10516012 Free PMC article. - Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.
Yang R, Wheeler CM, Chen X, Uematsu S, Takeda K, Akira S, Pastrana DV, Viscidi RP, Roden RB. Yang R, et al. J Virol. 2005 Jun;79(11):6741-50. doi: 10.1128/JVI.79.11.6741-6750.2005. J Virol. 2005. PMID: 15890912 Free PMC article. - Chapter 12: Prophylactic HPV vaccines: underlying mechanisms.
Stanley M, Lowy DR, Frazer I. Stanley M, et al. Vaccine. 2006 Aug 31;24 Suppl 3:S3/106-13. doi: 10.1016/j.vaccine.2006.05.110. Epub 2006 Jun 23. Vaccine. 2006. PMID: 16949996 Review.
Cited by
- Brucella abortus RB51 lipopolysaccharide influence as an adjuvant on the therapeutic efficacy of HPV16 L1 and HPV16 E7 DNA vaccines.
Shirmohammadi M, Soleimanjahi H, Kianmehr Z, Karimi H, Kaboudanian Ardestani S. Shirmohammadi M, et al. Iran J Basic Med Sci. 2021 Jan;24(1):92-97. doi: 10.22038/ijbms.2020.51043.11608. Iran J Basic Med Sci. 2021. PMID: 33643576 Free PMC article. - Optimizing a Human Papillomavirus Type 16 L1-Based Chimaeric Gene for Expression in Plants.
Hitzeroth II, Chabeda A, Whitehead MP, Graf M, Rybicki EP. Hitzeroth II, et al. Front Bioeng Biotechnol. 2018 Jul 16;6:101. doi: 10.3389/fbioe.2018.00101. eCollection 2018. Front Bioeng Biotechnol. 2018. PMID: 30062095 Free PMC article. - Development of chimeric candidate vaccine against HPV18: a proof of concept.
Wahiduzzaman M, Sharma C, Dey B, Bhatla N, Singh N. Wahiduzzaman M, et al. Immunol Res. 2015 Jun;62(2):189-97. doi: 10.1007/s12026-015-8650-4. Immunol Res. 2015. PMID: 25929429 - Suppression of HPV-16 late L1 5'-splice site SD3632 by binding of hnRNP D proteins and hnRNP A2/B1 to upstream AUAGUA RNA motifs.
Li X, Johansson C, Glahder J, Mossberg AK, Schwartz S. Li X, et al. Nucleic Acids Res. 2013 Dec;41(22):10488-508. doi: 10.1093/nar/gkt803. Epub 2013 Sep 5. Nucleic Acids Res. 2013. PMID: 24013563 Free PMC article. - Regulation of human papillomavirus gene expression by splicing and polyadenylation.
Johansson C, Schwartz S. Johansson C, et al. Nat Rev Microbiol. 2013 Apr;11(4):239-51. doi: 10.1038/nrmicro2984. Epub 2013 Mar 11. Nat Rev Microbiol. 2013. PMID: 23474685 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical